Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Synagis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Synagis was produced by AstraZeneca and AbbVie.

AZ, Sanofi’s nirsevimab hits primary endpoint in RSV trial

AZ, Sanofi’s nirsevimab hits primary endpoint in RSV trial

In addition to the MELODY trial, nirsevimab is being evaluated in the phase 2/3 MEDLEY trial, which is assessing the monoclonal antibody (mAb) compared to the older RSV treatment Synagis

Sobi shows strong growth despite haemophilia competition

Sobi shows strong growth despite haemophilia competition November also saw Sobi acquire rights to Synagis, the only approved respiratory syncytial virus (RSV) prophylaxis for high-risk infants from AstraZeneca. ... We completed the acquisition of Synagis in late January and are in the process of integrating

US, EU regulators back rapid reviews of AZ’s RSV med

US, EU regulators back rapid reviews of AZ’s RSV med MEDI8897 is a longer-acting follow-up to AZ’s Synagis (palivizumab), which is currently the only drug approved for preventing RSV in high-risk patients. ... Synagis has been a nice earner for AZ, making almost $700m in revenues in 2017, but has started

FDA clears Sobi’s Gamifant for ‘hyper-inflammation’ disease

FDA clears Sobi’s Gamifant for ‘hyper-inflammation’ disease Earlier this month, Sobi agreed to acquire the US rights to AstraZeneca’s respiratory syncytial virus (RSV) prevention drug Synagis (palivizumab) in a deal worth $1.5bn. ... Sobi's Guido Oelkers. “Gamifant will add significant strength to Sobi’s

AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi

AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi s focus on Synagis will enable infants in the US to continue benefiting from this important treatment.”. ... The addition of Synagis will become an important strategic catalyst for Sobi’s future development and will form a powerful platform for

1 2 3 4 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
TRIDUCIVE

Triducive are a strategic healthcare consultancy who produce communications that have practical, dynamic application that encourage behaviour change because of the...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...